Skip to main content
Springer logoLink to Springer
. 2024 Mar 7;32(4):216. doi: 10.1007/s00520-024-08381-x

Effectiveness of Comprehensive Intervention Programme on Quality of life, fatigue, self-efficacy, and psychosocial distress among head and neck cancer patients receiving radiotherapy

Shalini Ganesh Nayak 1, Anice George 1,, Krishna Sharan 2, Baby S Nayak 3, N Ravishankar 4
PMCID: PMC10917822  PMID: 38448712

Abstract

Purpose

The study aimed at evaluating the Effectiveness of Comprehensive Intervention Programme (CIP) on Quality of life (QOL), fatigue, self-efficacy, and psychosocial distress among Head and Neck Cancer (HNC) patients receiving radiotherapy treatment.

Methods

Single-centre non-RCT time series study was conducted among 134 HNC patients (67 observed, followed by 67 subjected to CIP). FACT- H&N, FACT-F, Cancer Behavior Inventory and psychosocial distress scales were used to assess QOL, fatigue, self-efficacy, and psychosocial distress respectively. CIP was provided to the intervention arm twice a week during the course of radiation therapy along with the standard care; the control arm received only standard care. Data were collected before commencing radiotherapy, and post-test assessments were carried out at the end of radiotherapy treatment, and at 3 and 6 months after completion of radiotherapy.

Results

Repeated measures ANOVA revealed a statistically significant improvement with CIP in QOL (F (1.917) = 454.103, p = 0.001), fatigue (F (2.106) = 183.775, p = 0.001), self-efficacy (F (2.429) = 190.861, p = 0.001), and psychosocial distress (F (2.288) = 290.105, p = 0.001) in the intervention arm.

Conclusion

The CIP implemented to address multitude of issues in HNC patients receiving radiotherapy, proved to be effective in reducing the impact of treatment on QOL, fatigue, self-efficacy and psychosocial distress in HNC patients receiving radiotherapy.

Keywords: Head and neck cancer, Quality of life, Fatigue, Self-efficacy, Psychosocial distress, Radiotherapy, Well-being

Introduction

Worldwide, Head and neck Cancers (HNC) are common at several regions. Globally, HNC accounts for more than 650,000 cases and 330,000 deaths annually [1]. These are group of cancers that develop in the tissues and organs located in the head and neck region. Radiotherapy (RT) has been used as primary source of treatment in all types of HNCs [2] and is often used in combination with surgery and/or chemotherapy [3]. RT is typically associated with significant side-effects, broadly classified as acute and chronic based on the time to manifestation. Though chronic toxicities are generally more concerning to the physicians, acute complications of RT such as mucositis, candidiasis, dysgeusia, and xerostomia significantly affect Quality of life (QOL) of HNC patients [4]. Treatment related side effects also lead to an inadequate nutritional intake, severe weight loss, lower disease related survival rates, patient related functional status and decreased QOL [5].

Despite advanced treatment methods in RT, the QOL is negatively impacted by HNC, even at early clinical stages [6]. QOL is important for HNC survivors and today as a study endpoint it is increasingly considered [7]. More than any other type of cancer, HNC patients place a high priority on their health-related Quality of Life (HR-QoL) [8]. The QOL of long-term HNC survivors is apparently poorer than that of the general population due to considerable functional limits caused by the illness and treatment [7]. Fatigue following RT among HNC patients is an unrecognised side effect [9, 10]. Fatigue stands out as one of the most prevalent side-effects of, and it impacts between 50 and 90% of individuals with HNC receiving RT [11, 12]. In HNC, fatigue may be directly related to malignancy, and to side-effects related to cancer treatment [10]. Burden of HNC is frequently manifested in psychosocial dysfunction, which may have a negative effect on QOL [13]. They have a wide range of psychological concerns throughout their illness, stressing the importance of therapeutic measures for preventing and treating psychosocial distress [14]. HNC patients also confront psychosocial distress such as anxiety and depression due to problems with salivation, eating and social contacts [13]. The high level of symptomatology such as mucositis, pain and xerostomia among HNC patients can manifest as social isolation, psychosocial distress and deteriorating QOL [15]. Patients are often anxious or fearful of suffering and death, uncertainty in the future and the treatment [16]. Throughout the illness trajectory, the HNC patients also have to cope with barrage of insults while facing debilitating treatment regimens, gruelling rehabilitation programmes and economic burdens. Hence, these psychosocial comorbidities in HNC patients must therefore be prevented, identified, and treated [14]. Depression is observed among 9.8 to 83.8% of patients, with a pooled estimated frequency of 63% (95% CI = 42–83) among HNC patients receiving radiation, with the heterogeneity (I2 = 97.66 percent; p < 0.001 which is statistically significant [17]. Enhancing the QOL of HNC patients by providing supportive care is the top priority in the healthcare [18]. The multifaceted nature of QOL issues among HNC patients also requires intervention with multiple components [19]. Considering such a wide spectrum of issues, more holistic interventions are needed to enhance the QOL, improve self-efficacy, and reduce fatigue and psychosocial distress of patients with HNC. Thus, this study aimed to evaluate the benefit of early implementation of Comprehensive Intervention Program (CIP) in improving QOL and self-efficacy, and reducing fatigue and psychosocial distress among HNC patients.

Materials and methods

A single centre non RCT time series study using pre and post-test design was conducted among 134 (67 in each arm) HNC patients receiving RT, selected by purposive sampling technique. The sample size was estimated by considering the QOL as the primary outcome variable. The following formula of comparison of means was used to find the sample size.

n=2(Z1-α/2+Z1-β)2σ2d2

n = needed minimum sample size for each arm, Z1-α/2 = 1.96; α = 0.05, Z1-β = 0.84 with 80% power, σ = population standard deviation of the primary outcome variable (SD = range/4; 156/4 = 39) and d = 20; i.e., clinically significant difference.

The data were collected between October 2020 and August 2022 from a tertiary care hospital of South India after obtaining clearance from Institutional Ethical Committee (IEC: 114/2019) and registration under Clinical Trial Registry of India (CTRI/2019/04/018820). The data from control arm was collected first and then from intervention arm, to avoid contamination. HNC patients in stage III, stage IVa and stage IVb receiving RT with or without chemotherapy with the curative intent, age between 40 and 80 years and Eastern Cooperative Oncology Group (ECOG) performance [20] status grade ≤ 1 were included in the study. Patients with early-stage vocal cord malignancy, with distant metastasis, secondary HNC, previous history of cancers and cancer treatments, with history of mental health disorders and patients having active infections or other comorbidities that could directly or indirectly impact on their QOL, were excluded. Control arm received standard care and intervention arm received CIP along with standard care. Follow-up was done for both arms at the end of intervention, three and six months after completion of intervention.

The baseline data on sample and disease characteristics were recorded on a proforma. QOL and fatigue were assessed by Functional Assessment of Cancer Therapy: Head & Neck (FACT-H&N) [21] & Functional Assessment of Cancer Therapy: Fatigue (FACT-F) [22] respectively after obtaining required permission from FACIT.org. Self-efficacy was measured through Cancer Behavior Inventory (CBI)—Brief form [23] with approval from PsychooncologyNDU.Wordpress.COM. A psychosocial distress scale was developed by the researcher [24] after extensive literature review [17]. The tool has 21 items with three responses “never,” “sometimes,” and “always.” The maximum possible score was 42 and minimum score was zero. Higher the score, lesser the psychosocial distress and vice versa. The content validity index of the tool was 0.98 and the reliability computed through Cronbach’s alpha was 0.87. The data were collected before starting radiotherapy (before CIP), at the end of radiotherapy (end of CIP), three and six months after the completion of radiotherapy.

Comprehensive intervention programme

We designed a psychosocial interventional package intended for improving the QOL among HNC patients receiving radiotherapy. The researcher consulted international and national experts in the subject for the development of appropriate intervention. Many of the unanswered questions from the need analysis and review of literature were discussed with professionals in the field before developing a culturally specific CIP, suitable for the research setting. It had five components: Seated exercise therapy, Reminiscence therapy, Board based games, educational sessions and Information booklet. Seated exercise therapy included a group of exercises performed to promote the wellbeing by sitting on an immovable chair with flat seat. This included warm-up exercises for five minutes such as feet taps, shoulder exercise, back twist, leg marches, and chair marches; moderate intensity exercises for 10 to 15 min, such as thigh stretches, calf stretches, upper back strengthening, arm strengthening, chest strengthening, hip strengthening, thigh strengthening; and finally, cool-down exercise for five minutes such as neck rotation, hand presses, stretching hands and legs, pelvic floor exercises, and walking around for one to two minutes. Reminiscence therapy was centred on telling stories depending on the session's focus. It was a “life review,” where the HNC patient looked back at his/her life and reflected the past pleasant experiences by vocally recalling to the questions related to the themes such as childhood, school days, family, occupation, marriage and children, visits and events, feelings about self, objects, festivals and holidays, entertainment, personal pictures and sharing the experience in the group. These topics were mentioned in cards; the participants were asked to select a card, and were then encouraged to share their memories with other patients, with particular emphasis on discussions that are pleasant to them; these were organized group sessions lasting 20 to 30 min. Board-based games included indoor, table top traditional games of India, such as carrom, snakes and ladders, monopoly, Ludo and Chinese checkers, which were played for 30–40 min. Seated exercise therapy, Reminiscence therapy and Board based games were administered twice a week for the duration of radiotherapy treatment. Educational session was prepared by considering the various aspects such as disease specific information of treatment modalities, detailed description of RT, preparation for RT, chemotherapy, common side effects of RT, modes of communication in difficult verbal communication, nutritional management, management of pain and other symptoms of RT and anticipatory guidance. This session was delivered to the HNC patient along with family member for the duration of 45 min prior to RT and during the fourth week of RT. The information booklet was tailored based on the needs of the HNC patients after RT, supplemented with appropriate pictures. The content of the booklet included oral care, personal hygiene and care of RT site, nutritional management, prevention of infection, distraction from ruminative thoughts and other discharge instructions. The intervention was validated by nine subject experts and pilot tested among five HNC patients for the feasibility. The intervention was implemented adhering to the protocol by a single researcher throughout to maintain the consistency. A checklist on duration and missing of sessions was maintained by the researcher to assess the adherence.

Results

The coded data were entered and analysed by Statistical Package for the Social Sciences (SPSS) version 16. Patients enrolled in the study (134) and the participants’ attrition is presented in Fig. 1. Repeated measures ANOVA with general linear model was computed and the last recorded value was substituted for the intention to treat (ITT) analysis. To find whether difference occurred is true Bonferroni correction and pairwise comparison was done. For the lost to follow-up data, LOCF (last observation carry forward) was used.

Fig. 1.

Fig. 1

Flow diagram of study participants

The demographic findings showed that most participants belonged to the age group of 51–70 years, i.e., 44 (65.6%) from intervention arm and 49 (73.1%) from control arm, with the mean ± SD age of 56.1 ± 9.4 years and 57.6 ± 8.3 years respectively. Sample had male preponderance, with 58 (86.6%) and 57 (85.1%) in intervention and control arm respectively. Approximately half of the sample, i.e., 31 (46.3%) from intervention arm and 35 (52.3%) from control arm had only primary education. Predominant site of cancer was oral cavity, i.e., 34 (50.7%) and 40 (59.7%) of the participants from intervention and control arm respectively. Regarding the stage of cancer, 37 (55.2%) of the participants from intervention arm and 39 (58.2%) from control arm were diagnosed to have the Stage IVa disease. Chi-square computed to assess the homogeneity of intervention and control arm on baseline demographic characteristics and disease related variables showed that the groups were similar (p > 0.05) (Table 1 and 2).

Table 1.

Chi-square to assess the homogeneity of baseline socio-demographic variables

Socio-demographic Variables Intervention Arm
(n = 67)
Control arm
(n = 67)
P value
f % f %
Mean age (mean ± SD) 56.1 ± 9.4 57.6 ± 8.3
Age group (in years)
  40–50 20 29.9 14 20.9 0.37
  51–60 22 32.8 31 46.3
  61–70 22 32.8 18 26.8
  71–80 03 4.5 04 6.0
Gender
  Male 58 86.6 57 85.1 0.80
  Female 09 13.4 10 14.9
Marital status
  Living with spouse 61 91.0 60 89.6 0.95
  Widow/widower 05 7.5 06 8.9
  Divorced 00 00 00 00
  Unmarried 01 1.5 01 1.5
Educational qualification
  Primary 31 46.3 35 52.3 0.75
  High school 26 38.8 22 32.8
  Pre-University and above 10 14.9 10 14.9
Occupation
  Agriculture 14 20.9 16 23.9 0.19
  Business 03 4.5 10 14.9
  Cooli 16 23.9 14 20.9
  Others 19 28.4 19 28.4
  Nil 15 22.3 08 11.9
Type of family
  Nuclear 41 61.2 37 55.2 0.33
  Joint 15 22.4 12 17.9
  Extended 11 16.4 18 26.9
Family income per month in rupees
   ≤ 6000 23 34.3 21 31.3
  6001–18,000 34 50.7 27 40.3 0.29
  18,001–30,000 06 9.0 07 10.4
  30,001–45,000 02 3.0 06 9.0
  45,001–60,000 02 3.0 03 4.5
  Above 60,000 00 00 03 4.5
Type of diet
  Vegetarian 10 14.9 10 14.9
  Non-vegetarian 00 00 00 00 1.0
  Mixed 57 85.1 57 85.1

Table 2.

Chi-square to assess the homogeneity of baseline disease related variables

Disease related variables Intervention Arm
(n = 67)
Control arm
(n = 67)
P value
f % f %
Site of cancer
  Pharynx 21 31.3 15 22.4 0.17
  Larynx 05 7.5 01 1.5
  Oral cavity (Buccal mucosa/ Tongue/ Alveolus) 34 50.7 40 59.7
  Others 07 10.4 11 16.4
Stage of cancer
  Stage III 13 19.4 12 17.9 0.94
  Stage IVa 37 55.2 39 58.2
  Stage IVb 17 25.4 16 23.9
Duration of illness
  3 months and less 18 26.9 25 37.3 0.20
  More than three months 49 73.1 42 62.7
Treatment modality
  Only radiation therapy 05 7.4 04 6.0 0.34
  Radiation therapy & Chemotherapy 32 47.8 38 56.7
  Surgery, Radiotherapy and chemotherapy 17 25.4 09 13.4
  Any other treatment (surgery + radiotherapy) 13 19.4 16 23.9
Radiotherapy dose
  60 Gy/30#/6 weeks 19 28.4 22 32.8 0.46
  66 Gy/33#/6.5 weeks & 70 Gy/35#/7 weeks 48 71.6 45 67.2
Co-morbid illness
  Yes 10 14.9 16 23.9 0.19
  No 57 85.1 51 76.1

Description of baseline QOL, fatigue, self-efficacy and psychosocial distress

Baseline mean and standard deviation of QOL, fatigue, self-efficacy and psychosocial distress are presented in Table 3. Independent sample ‘t’ test computed shows that the data were not significantly different in both the arms at baseline and the groups were comparable.

Table 3.

Comparison of intervention and control arm participants on baseline QOL, fatigue, self-efficacy and psychosocial distress

N = 134
Outcome variables Intervention arm (n = 67) Control arm (n = 67) 95% of CI ‘t’ value p value
Mean  + SD Mean  + SD LL UL
QOL 85.52 18.75 93.01 18.60 1.09 13.87 2.32 0.12
Fatigue 36.87 10.39 38.57 9.08 -1.63 5.03 1.00 0.32
Self-efficacy 70.31 13.88 72.98 12.76 -1.88 7.23 1.15 0.23
Psychosocial distress 25.79 6.34 28.10 6.09 0.19 4.43 2.15 0.33

Description of pre and post-test QOL, fatigue, self-efficacy and psychosocial distress

Pre and post-test QOL, fatigue, self-efficacy, and psychosocial distress are shown in Table 4.

Table 4.

Pre and post-test QOL, fatigue, self-efficacy, and psychosocial distress among the participants of intervention and control arm

N = 134
Outcome variables Study arms Baseline At the end of intervention After three months After 6 months
Mean  + SD Mean  + SD Mean  + SD Mean  + SD
QOL domains

  Physical wellbeing

(0–28)

Intervention arm 15.70 4.31 18.00 3.24 24.09 1.87 26.20 1.62
Control arm 16.91 2.81 10.62 5.07 21.52 2.27 24.89 2.49

  Social wellbeing

(0–28)

Intervention arm 17.22 5.53 20.49 2.88 22.23 5.74 21.73 2.24
Control arm 18.52 4.95 18.48 3.84 20.31 2.76 20.81 2.92

  Emotional wellbeing

(0–24)

Intervention arm 18.32 4.10 19.90 1.98 22.51 1.41 23.45 1.04
Control arm 19.68 2.85 14.00 4.05 20.82 1.98 22.31 2.21

  Functional wellbeing

(0–28)

Intervention arm 14.92 6.04 14.90 3.56 23.74 3.10 25.28 2.97
Control arm 16.85 6.72 7.45 4.09 18.30 3.86 22.44 3.19

  H&N subscale

(0–40)

Intervention arm 19.34 6.10 20.18 2.65 29.66 3.02 33.53 3.12
Control arm 21.04 6.87 12.22 3.75 26.60 3.96 31.38 4.18
  FACT-H&N total (QOL) (0–148) Intervention arm 85.52 18.75 93.49 8.67 122.27 8.57 130.20 8.25
Control arm 93.01 18.60 62.78 11.49 107.57 9.18 121.83 10.96
  Fatigue Intervention arm 36.86 10.39 34.87 5.22 44.59 4.50 47.07 3.78
Control arm 38.56 9.08 20.45 7.99 38.39 6.49 43.59 5.69
  Self-efficacy Intervention arm 70.31 13.88 89.20 8.14 97.19 5.35 101.76 4.46
Control arm 72.98 12.76 61.16 17.11 86.82 13.47 92.50 11.03
  Psycho-social distress Intervention arm 25.79 6.33 27.72 3.64 37.48 2.49 39.51 2.49
Control arm 28.10 6.09 17.83 5.18 31.19 4.05 35.26 4.62

As shown in Table 4. the mean (± SD) of QOL score of intervention arm was 85.52 (± 18.75) and control arm was 93.01 (± 18.60), indicating that the baseline QOL was apparently better in control arm. Mean scores in all the domains of QOL had improved slightly in the participants of intervention arm at the end of intervention except for functional wellbeing. The mean (± SD) scores in all the domains steadily improved among the participants of both arms from the end of intervention to 3 and 6 months. The intervention arm maintained higher mean scores compared to control arm in all the domains of QOL at follow up observations.

Fatigue in both intervention and control arm worsened from baseline to the end of intervention. However, it was comparatively less impacted in the intervention arm. Mean (± SD) scores of self-efficacy scores improved among the participants of intervention arm from baseline to the end of intervention i.e. 70.31 (± 13.88) to 89.20 (± 8.14) in comparison to control arm. Decrease in the mean (± SD) scores of psychosocial distress in the control arm from baseline 28.10 (± 6.09) to 17.83 (± 5.18) was observed indicating more psychosocial distress among the participants at the end of radiotherapy comparing to intervention arm. There was steady increase in the mean (± SD) score of fatigue, self-efficacy and psychosocial distress scores at 3 and 6 months among the participants of both arms. The intervention arm maintained higher mean (± SD) scores throughout the follow up observations (Table 4).

Effectiveness of comprehensive intervention programme

Findings revealed statistically significant difference in QOL (F (1,119) = 77.507, p = 0.001, Np2= 0.394), fatigue (F (1,119) = 45.067, p = 0.001, Np2= 0.275), self-efficacy (F (1,119) = 73.762, p = 0.001, Np2= 0.385) and psychosocial distress (F (1,119) = 101.788, p = 0.001, Np2= 0.461) between the subjects of intervention and control arm. The effect size of QOL (0.394), fatigue (0.275), self-efficacy (0.385) and psychosocial distress (0.461) between the arms shows moderate statistical significance. The interaction effect (time X group) of QOL (F (1) = 5.47, p = 0.021) and psychosocial distress (F (1) = 13.090, p = 0.001) was significant, indicating that the group changed over time and the change was different across the groups. However, it was not significant for fatigue (F (1) = 1.271, p = 0.262) and self-efficacy (F (1) = 2.671, p = 0.105). The interaction effect (time X group) was considered to determine the significant variation in the change across the groups (Table 5).

Table 5.

Repeated Measures ANOVA on QOL, fatigue, self-efficacy, and psychosocial distress scores between intervention and control arm HNC patients

N = 134
Variables Mean square F value df p value Np2
QOL
  Between group (n = 134) 16417.257 77.507 1,119 0.001 0.394
  Within group (n = 67) 94583.006 454.103 1.917 0.001 0.792
  Time X group 1188.01 5.47 1 0.021 0.044
Fatigue
  Between group (n = 134) 3687.780 45.067 1,119 0.001 0.275
  Within group (n = 67) 10088.235 183.775 2.106 0.001 0.607
  Time X group 69.367 1.271 1 0.262 0.011
Self-efficacy
  Between group (n = 134) 15131.302 73.762 1,119 0.001 0.385
  Within group (n = 67) 23916.695 190.861 2.429 0.001 0.618
  Time X group 323.400 2.671 1 0.105 0.022
Psychosocial distress
  Between group (n = 134) 2479.177 101.788 1,119 0.001 0.461
  Within group (n = 67) 7259.451 290.105 2.288 0.001 0.709
  Time X group 331.153 13.090 1 0.001 0.099

df degree of freedom, Np2 Partial Eta Squared (effect size)

The difference in QOL, fatigue, self-efficacy and psycho-social distress scores was plotted in Fig. 2.

Fig. 2.

Fig. 2

Profile plot showing mean QOL (A), fatigue (B), self-efficacy (C) and psychosocial distress (D) scores

Discussion

In this study, effectiveness of CIP was evaluated and demonstrated to be effective in improving the QOL, decreasing fatigue, improving self-efficacy and reducing psychosocial distress of HNC patients. These findings are in line with the results of a study on effectiveness of a “Comprehensive oral care programme” by Lee et.al., among HNC patients undergoing RT, which showed statistically significant (P < 0.05) lower speech problems (p = 0.034) and swallowing problems (p = 0.035) in the domain of QOL [25]. Similar findings were identified in a study conducted by Lin et al., to assess the effectiveness of “mobile oral care app,” which had an educational content to improve QOL. The results of this study showed significant improvement in QOL among the participants of intervention group (p < 0.001) [26]. The literature supports the benefits of exercise therapy and psychosocial programmes in improving the QOL among HNC patients [27, 28]. A systematic review conducted by Lynch et al., to assess the “effectiveness of physical activity interventions” showed improvement in QOL along with other symptoms such as pain and sleep [29]. Findings of another systematic review summarised from 16 research articles by Capozzi et al., to assess the effectiveness of physical activity on QOL among HNC patients also demonstrated feasibility and safety of physical interventions along with improvement in QOL and physical activity [30]. Systematic review on effectiveness of “psychological interventions” on QOL by Calver et. al., demonstrated inconclusive results due to insufficient data (Calver, Tickle, Moghaddam, Biswas, & Macmillan, 2018). Enhancing the QOL among HNC patients requires a comprehensive and multidimensional approach. Hence, it is quiet challenging to conclude the best and most effective intervention and time of implementation owing to the heterogeneity in sites of cancer, use of diverse populace, variation in type and rigour of interventions used, non-comprehensiveness and differing outcomes.

In the current study, CIP demonstrated effective in reducing the fatigue. The findings of this study are supported by few of the published research studies. Grote et al., conducted a pilot randomised controlled trial at Germany among 20 HNC patients receiving RT with “progressive resistance training” as an intervention. They reported the intervention to be beneficial in reducing the general fatigue, though not statistically significant (p = 0.393) [31]. A systematic review by Lynch et al., and Capozzi et al., also reported reduction in fatigue among HNC patients [29, 30]. Exercise training during anticancer therapy has shown improvement in physical function and reduction in cancer related fatigue. Hence, exercise should be regarded as a complementary therapy to RT in order to reduce treatment-related side effects and speed up recovery [32]. Patients diagnosed with HNC have low level of physical activity and sedentary behaviour [33]. Low- to moderate-intensity exercise, such as sitting exercise, can help to reduce fatigue over time [34]. Among older adults, seated exercises can have positive effect on cognition, strength, activity and QOL [35].

As the HNC patients suffer from multitude of problems, the interventions should be focused on effective self-management to enhance self-efficacy. However, scientific evidence on interventions focussing on the improvement of self-efficacy is minimal. Functional restrictions attributed by HNC may lead into psychosocial distress. CIP was effective in improving self-efficacy and decreasing psychosocial distress, as it combined multiple components and addressed the diverse needs of HNC patients. Reminiscence therapy used in CIP proved to significantly reduce anxiety and depression, in addition to improving social functioning, mental and physical health [36]. It is an effective and safe nursing intervention in improving self-esteem, emotional and physical wellbeing [37] and decreasing adaptation difficulties among elderly [38]. Board based games have proven to be effective in improving physical activity, cognitive function, enhancing motivation, interpersonal interaction and are thus regarded as effective complementary therapy to improve clinical symptoms [39]. Educational interventions also improve the physical symptoms and psychological outcomes [40]. These interventions can also reduce the fatigue and related symptoms, decrease anxiety and improve QOL [41]. While our study was conducted in India, its implications extend beyond the borders of our nation. Although our data is rooted in the Indian context, the patterns and trends in HNC are align closely with reports from other countries in Aasia facing comparable demographic transitions and public health challenges [42]. This suggests a degree of generalizability of our results to countries with similar profile. However, we acknowledge the need for further research to confirm the generalizability of our findings.

Implications

HNC patients require multimodal treatment modalities and oftentimes, structural, functional, and aesthetic losses result with HNC treatment. From the time of diagnosis, treatment to post treatment follow-up, it is a difficult and lengthy journey which makes HNC one of the most painful cancer experiences mentally and emotionally. The clinical focus during treatment and post-treatment is changing with the emphasis on identifying and minimising treatment side effects and rehabbing the functional deficiencies. Burden of physical symptoms impair the physical, emotional, social and functional wellbeing impacting the QOL. Supporting patients and providing psychosocial services constitute crucial elements of cancer care. Comprehensive cancer centres must offer a range of these services to ensure they deliver high-quality and comprehensive care to cancer patients. The delivery of these services initiates upon diagnosis, extends throughout cancer treatment, and transitions accordingly into survivorship or end-of-life stages [43]. Evidence based interventions and novel approaches for oncology practitioners to enhance the QOL and treatment adherence among HNC involve regular screening for distress, educational initiatives, establishment of symptom management clinics, and integration of technology to maintain close communication with patients throughout their treatment journey [44]. Addressing multifaceted QOL challenges faced by HNC patients also necessitates the comprehensive interventions [19]. The CIP implemented to address multitude of issues proved to be effective in improving the QOL, reducing the fatigue, improving the self-efficacy and reducing the psychosocial distress in this distinct group of patient population. Moreover, this benefit was sustained even after six months following treatment. With these promising findings, the CIP also can be implemented in the ongoing routine care of the HNC patients. Hospitals and healthcare facilities may need to allocate resources to implement such tailored interventions to HNC patients. Training healthcare staff to prioritise the needs of patients, strategies such as patient education are crucial [45].

Strengths and limitations

A comprehensive intervention was required to support and strengthen the resilience of HNC patients as these patients face multitude of problems. To the best of our knowledge this study is the first of its kind attempted to evaluate the effectiveness of comprehensive intervention for the holistic wellbeing of HNC patients. The psychosocial distress scale used in the study was developed based on the findings of focus group discussion among HNC patients emphasizing on the distress experienced during radiotherapy and a systematic review of psychosocial distress of HNC patients during radiotherapy. Hence it was most appropriate for the HNC population. Recruitment and data collection among intervention arm was done only after completing recruitment and collecting two follow-up data from the participants of control arm, and this did not lead into any bias or contamination.

One of the important limitations of the study is that the data were collected amidst of COVID pandemic, which might have impacted the outcome variables, especially psychosocial distress and self-efficacy. Secondly, inclusion of a mix of multiple subsites of HNC such as cancer of oral cavity, pharynx and larynx- which could have potentially unique demands, may pose limitations on generalisation of findings. Thirdly the study was not a randomized control trial and participants were not blinded, hence limits the generalization of findings. Despite best efforts, implementation of the intervention faced few challenges. One of the challenges faced during implementation of the intervention was, difficulty in engaging into the intervention, as the painful procedures (such as tracheostomy and insertion of ryles tube) for few participants were performed on the same day of intervention scheduled. Few other participants experienced fatigue due to chemotherapy schedules which were overlapping with the day of research intervention.

Conclusion

HNC patients require multimodal treatment modalities and oftentimes, structural, functional, and aesthetic losses result with HNC treatment. From the time of diagnosis, treatment to post treatment follow-up, it is a difficult and lengthy journey which makes HNC one of the most painful cancer experiences mentally and emotionally. The clinical focus during treatment and post-treatment is changing with the emphasis on identifying and minimising treatment side effects and rehabbing the functional deficiencies. The CIP implemented to address multitude of issues proved to be effective in improving the QOL, reducing the fatigue, improving the self-efficacy and reducing the psychosocial distress in this distinct group of patient population.

Author contribution

All authors contributed to the study conception and design. Material Preparation was done by Shalini Ganesh Nayak, Anice George, Krishna Sharan and Baby S Nayak. Data were collected by Shalini Ganesh Nayak. Data analysis was done by Shalini Ganesh Nayak and Ravishankar N. The first draft of manuscript was written by Shalini Ganesh Nayak and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Funding

Open access funding provided by Manipal Academy of Higher Education, Manipal

Data availability

As the study participants did not agree to their data to be shared publicly, the data of this study are not publicly available. Participants provided consent only for the result to be written up for publication.

Declarations

Ethics approval

This was a performed in line with principles of the Declaration of Helsinki. Approval was granted by the Institutional Ethics Committee of Kasturba Medical College and Kasturba Hospital (IEC 114/2019) on 13th February 2019.

Consent to participate

Informed consent was obtained from all the participants included in the study.

Consent for publication

Consent to publish was received from all individual participants included in the study.

Competing interests

The authors declare no competing interests.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Stenson KM (2022) Epidemiology and risk factors for head and neck cancer - UpToDate. https://www.uptodate.com/contents/epidemiology-and-risk-factors-for-head-and-neck-cancer?search=headandneckcancersepidemiology&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1. Accessed 7 Apr 2022
  • 2.Cognetti DM, Weber RS, Lai SY. Head and neck cancer: an evolving treatment paradigm. Cancer. 2008;113:1911–1932. doi: 10.1002/cncr.23654.Head. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Bharatha A, Yu E, Symons SP, Bartlett ES. Pictorial essay: Early- and late-term effects of radiotherapy in head and neck imaging. Can Assoc Radiol J. 2012;63:119–128. doi: 10.1016/j.carj.2010.09.004. [DOI] [PubMed] [Google Scholar]
  • 4.de Souza Tolentino E, Centurion BS, Ferreira LH, et al. Oral adverse effects of head and neck radiotherapy: Literature review and suggestion of a clinical oral care guideline for irradiated patients. J Appl Oral Sci. 2011;19:448–454. doi: 10.1590/S1678-77572011000500003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Lønbro S, Petersen GB, Andersen JR, Johansen J. Prediction of critical weight loss during radiation treatment in head and neck cancer patients is dependent on BMI. Support Care Cancer. 2016;24:2101–2109. doi: 10.1007/s00520-015-2999-8. [DOI] [PubMed] [Google Scholar]
  • 6.Milecki J, Żmijewska-Tomczak M, Osmola K, Wierzbicka M. The impact of radiotherapy on the quality of life in patients with early-stage clinical head and neck cancer. Otolaryngol Pol. 2021;75:1–8. doi: 10.5604/01.3001.0014.8759. [DOI] [PubMed] [Google Scholar]
  • 7.Liao LJ, Hsu WL, Lo WC, et al. Health-related quality of life and utility in head and neck cancer survivors. BMC Cancer. 2019;19:1–10. doi: 10.1186/s12885-019-5614-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Sharma Y, Mishra G, Parikh V. Quality of life in head and neck cancer patients. Indian J Otolaryngol Head Neck Surg. 2019;71:927–932. doi: 10.1007/s12070-019-01620-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Jereczek-Fossa BA, Santoro L, Alterio D, et al. {A figure is presented}Fatigue during head-and-neck radiotherapy: prospective study on 117 consecutive patients. Int J Radiat Oncol Biol Phys. 2007;68:403–415. doi: 10.1016/j.ijrobp.2007.01.024. [DOI] [PubMed] [Google Scholar]
  • 10.Twomey R, Culos-Reed SN, Millet GY, Lau H. Fatigue following head and neck cancer radiotherapy: an unrecognized side effect of modern radiotherapy techniques? Transl Cancer Res. 2017;6:S1471–S1475. doi: 10.21037/tcr.2017.11.12. [DOI] [Google Scholar]
  • 11.Brook IG. Early side effects of radiation treatment for head and neck cancer. Cancer/Radiothérapie. 2021;25:507–513. doi: 10.1016/j.canrad.2021.02.001. [DOI] [PubMed] [Google Scholar]
  • 12.Avelar JM de P, Nicolussi AC, Toneti BF et al (2019) Fatigue in patients with head and neck cancer undergoing radiation therapy: a prospective study. Rev Lat Am Enfermagem 27:. 10.1590/1518-8345.2813-3168 [DOI] [PMC free article] [PubMed]
  • 13.Wu YS, Lin PY, Chien CY, et al. Anxiety and depression in patients with head and neck cancer: 6-month follow-up study. Neuropsychiatr Dis Treat. 2016;12:1029–1036. doi: 10.2147/NDT.S103203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Smith JD, Shuman AG, Riba MB (2017) Psychosocial issues in patients with head and neck cancer: an updated review with a focus on clinical interventions. Curr Psychiatry Rep 19:. 10.1007/s11920-017-0811-9 [DOI] [PubMed]
  • 15.Semple C, Parahoo K, Norman A, et al. Psychosocial interventions for patients with head and neck cancer. Cochrane Database Syst Rev. 2013;16:1–44. doi: 10.1097/XEB.0000000000000015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Jagannathan A, Juvva S. Emotions and coping of patients with head and neck cancers after diagnosis: a qualitative content analysis. J Postgrad Med. 2016;62:143–149. doi: 10.4103/0022-3859.184273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Nayak SG, Sharan K, Chakrabarty J, et al. Psychosocial distress of head neck cancer (HNC) Patients receiving radiotherapy: a systematic review. Asian Pac J Cancer Prev. 2022;23:1827–1835. doi: 10.31557/APJCP.2022.23.6.1827. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.So WKW, Wong CL, Choi KC, et al. A mixed-methods study of unmet supportive care needs among head and neck cancer survivors. Cancer Nurs. 2019;42:67–78. doi: 10.1097/NCC.0000000000000542. [DOI] [PubMed] [Google Scholar]
  • 19.Nayak SG, George A, Sharan K et al (2024) Interventions to improve quality of life in patients with head and neck cancers receiving radiation therapy: a scoping review. Support Care Cancer 32:. 10.1007/s00520-023-08197-1 [DOI] [PubMed]
  • 20.Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649–655. doi: 10.1097/00000421-198212000-00014. [DOI] [PubMed] [Google Scholar]
  • 21.List MA, D’Antonio LL, Cella DF, et al. The performance status scale for head and neck cancer patients and the functional assessment of cancer therapy-head and neck scale: a study of utility and validity. Cancer. 1996;77:2294–2301. doi: 10.1002/(SICI)1097-0142(19960601)77:11&#x0003c;2294::AID-CNCR17&#x0003e;3.0.CO;2-S. [DOI] [PubMed] [Google Scholar]
  • 22.Yellen SB, Cella DF, Webster K, et al. Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manage. 1997;13:63–74. doi: 10.1016/S0885-3924(96)00274-6. [DOI] [PubMed] [Google Scholar]
  • 23.Heitzmann CA, Merluzzi TV, Jean-Pierre P, et al. Psycho-Oncology - 2011 - Heitzmann - assessing self-efficacy for coping with cancer development and psychometric analysis.pdf. Psychooncology. 2011;20:302–312. doi: 10.1002/pon.1735. [DOI] [PubMed] [Google Scholar]
  • 24.Nayak SG, Sharan K, George A. Attributes of psychosocial distress from the perspectives of head-and-neck cancer patients – a thematic analysis. Indian J Palliat Care. 2023;29:181–185. doi: 10.25259/ijpc_185_2022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Lee HJ, Han DH, Kim JH, Wu HG. The effect of comprehensive oral care program on oral health and quality of life in patients undergoing radiotherapy for head and neck cancer: a quasi-experimental case-control study. Medicine (Baltimore) 2021;100:e25540. doi: 10.1097/MD.0000000000025540. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Lin TH, Wang YM, Huang CY. Effects of a mobile oral care app on oral mucositis, pain, nutritional status, and quality of life in patients with head and neck cancer: a quasi-experimental study. Int J Nurs Pract. 2022;28:1–11. doi: 10.1111/ijn.13042. [DOI] [PubMed] [Google Scholar]
  • 27.Kilbourn KM, Anderson D, Costenaro A, et al. Feasibility of EASE: a psychosocial program to improve symptom management in head and neck cancer patients. Support Care Cancer. 2013;21:191–200. doi: 10.1007/s00520-012-1510-z. [DOI] [PubMed] [Google Scholar]
  • 28.Burgos-Mansilla B, Galiano-Castillo N, Lozano-Lozano M et al (2021) Effect of physical therapy modalities on quality of life of head and neck cancer survivors: a systematic review with meta-analysis. J Clin Med 10:. 10.3390/jcm10204696 [DOI] [PMC free article] [PubMed]
  • 29.Lynch PT, Horani S, Lee R, et al. Effectiveness of physical activity interventions in improving objective and patient-reported outcomes in head and neck cancer survivors: a systematic review. Oral Oncol. 2021;117:105253. doi: 10.1016/j.oraloncology.2021.105253. [DOI] [PubMed] [Google Scholar]
  • 30.Capozzi LC, Nishimura KC, McNeely ML, et al. The impact of physical activity on health-related fitness and quality of life for patients with head and neck cancer: a systematic review. Br J Sports Med. 2016;50:325–338. doi: 10.1136/bjsports-2015-094684. [DOI] [PubMed] [Google Scholar]
  • 31.Grote M, Maihöfer C, Weigl M, et al. Progressive resistance training in cachectic head and neck cancer patients undergoing radiotherapy: a randomized controlled pilot feasibility trial. Radiat Oncol. 2018;13:1–10. doi: 10.1186/s13014-018-1157-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Piraux E, Caty G, Aboubakar Nana F, Reychler G. Effects of exercise therapy in cancer patients undergoing radiotherapy treatment: a narrative review. SAGE Open Med. 2020;8:205031212092265. doi: 10.1177/2050312120922657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Karczewska-Lindinger M, Tuomi L, Fridolfsson J, et al. Low physical activity in patients diagnosed with head and neck cancer. Laryngoscope Investig Otolaryngol. 2021;6:747–755. doi: 10.1002/lio2.610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Headley JA, Ownby KK, John LD. The effect of seated exercise on fatigue and quality of life in women with advanced breast cancer. Oncol Nurs Forum. 2004;31:977–983. doi: 10.1188/04.ONF.977-983. [DOI] [PubMed] [Google Scholar]
  • 35.Sexton BP, Taylor NF. To sit or not to sit? A systematic review and meta-analysis of seated exercise for older adults. Australas J Ageing. 2019;38:15–27. doi: 10.1111/ajag.12603. [DOI] [PubMed] [Google Scholar]
  • 36.Musavi M, Mohammadian S, Mohammadinezhad B. The effect of group integrative reminiscence therapy on mental health among older women living in Iranian nursing homes. Nurs Open. 2017;4:303–309. doi: 10.1002/nop2.101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Ramadan Abdel-Aziz H, AbdElkhalek Ahmed HA. The effect of group reminiscence therapy on self-esteem and emotional well-being of older adults. Cent Eur J Nurs Midwifery. 2021;12:513–520. doi: 10.15452/cejnm.2021.12.0027. [DOI] [Google Scholar]
  • 38.Kaplan T, Keser İ. The effect of individual reminiscence therapy on adaptation difficulties of the elderly: a randomized clinical trial. Psychogeriatrics. 2021;21:869–880. doi: 10.1111/psyg.12761. [DOI] [PubMed] [Google Scholar]
  • 39.Noda S, Shirotsuki K, Nakao M (2019) The effectiveness of intervention with board games: A systematic review. Biopsychosoc Med 13:. 10.1186/s13030-019-0164-1 [DOI] [PMC free article] [PubMed]
  • 40.Waller A, Forshaw K, Bryant J, Mair S. Interventions for preparing patients for chemotherapy and radiotherapy: a systematic review. Support Care Cancer. 2014;22:2297–2308. doi: 10.1007/s00520-014-2303-3. [DOI] [PubMed] [Google Scholar]
  • 41.Bennett S, Pigott A, Em B, et al. Educational interventions for the management of cancer-related fatigue in adults (Review) Cochrane Database Syst Rev. 2016 doi: 10.1002/14651858.CD008144.pub2.www.cochranelibrary.com. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Chauhan R, Trivedi V, Rani R, Singh U. A study of head and neck cancer patients with reference to tobacco use, gender, and subsite distribution. South Asian J Cancer. 2022;11:046–051. doi: 10.1055/s-0041-1740601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Chakraborty R, Majhail NS, Abraham J (2022) Psychosocial and patient support services in comprehensive cancer centers. Compr Cancer Cent 93–106. 10.1007/978-3-030-82052-7_11 [PubMed]
  • 44.Lynn Miller J, Evers JE. Barriers to adherence to cancer treatments among head and neck cancer patients. J Adv Pract Oncol. 2022;13:515–523. doi: 10.6004/jadpro.2022.13.5.5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Pantoja T, Opiyo N, Lewin S et al (2017) Implementation strategies for health systems in low‐income countries: an overview of systematic reviews.10.1002/14651858.CD011086.pub2.www.cochranelibrary.com [DOI] [PMC free article] [PubMed]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

As the study participants did not agree to their data to be shared publicly, the data of this study are not publicly available. Participants provided consent only for the result to be written up for publication.


Articles from Supportive Care in Cancer are provided here courtesy of Springer

RESOURCES